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Abstract
Background: Allergy to bites of blood-sucking insects, including biting midges, can 
affect both human and veterinary patients. Horses are often suffering from an IgE-
mediated allergic dermatitis caused by bites of midges (Culicoides spp). With the aim to 
improve allergen immunotherapy (AIT), numerous Culicoides allergens have been pro-
duced as recombinant (r-) proteins. This study aimed to test a comprehensive panel of 
differently expressed Culicoides r-allergens on a cohort of IBH-affected and control 
horses using an allergen microarray.
Methods: IgE levels to 27 Culicoides r-allergens, including 8 previously unpublished al-
lergens, of which 11 were expressed in more than one expression system, were deter-
mined in sera from 347 horses. ROC analyses were carried out, cut-offs selected using 
a specificity of 95% and seropositivity rates compared between horses affected with 
insect bite hypersensitivity (IBH) and control horses. The combination of r-allergens 
giving the best performing test was determined using logistic regression analysis.
Results: Seropositivity was significantly higher in IBH horses compared with controls 
for 25 r-allergens. Nine Culicoides r-allergens were major allergens for IBH with seven 
of them binding IgE in sera from > 70% of the IBH-affected horses. Combination 
of these top seven r-allergens could diagnose > 90% of IBH-affected horses with a 
specificity of > 95%. Correlation between differently expressed r-allergens was usu-
ally high (mean = 0.69, range: 0.28-0.91).
Conclusion: This microarray will be a powerful tool for the development of compo-
nent-resolved, patient-tailored AIT for IBH and could be useful for the study of allergy 
to biting midges in humans and other species.
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1  | INTRODUC TION
Allergy to biting insects, including biting midges, is affecting both 
human and veterinary patients.1 Insect bite hypersensitivity (IBH) is 
a seasonally recurrent, strongly pruritic allergic dermatitis2-4 of horses 
caused by biting midges of the genus Culicoides and is thus also in-
creasingly named Culicoides hypersensitivity (CH). IBH occurs nearly 
worldwide with a prevalence of 3% to 60%, depending on breed, 
family and environment.5 IBH is not affecting horses in Iceland be-
cause of the absence of the causative Culicoides spp. However, horses 
imported as adults from Iceland to Culicoides-rich environments, for 
example, in mainland Europe, have a high prevalence of IBH (>50%), 
while the prevalence of IBH in horses of the Icelandic breed born in 
mainland Europe is only 8%-10% as reviewed in.5 The Culicoides (C.) 
species causing IBH can vary depending on the geographical location: 
C obsoletus (Cul o) is the most common species found around horses 
in both North America and Europe.6,7 C nubeculosus (Cul n) is found 
rather rarely in European countries8 but can be bred under laboratory 
conditions.9 IBH is characterized by type I, IgE-mediated reactions (re-
viewed in Ref. [5,10]) to salivary gland proteins from Culicoides spp.11-
13 IgE antibodies binding to the natural allergens8,14,15 as well as to 
Culicoides recombinant (r-) allergens16-18 have been demonstrated in 
sera of IBH-affected horses. Histamine and sulfidoleukotriene release 
assay with Culicoides allergens19-21 further support type I reactions in 
IBH, usually followed by a late-phase reaction.22-24
Development of specific and sensitive diagnostic tests as well as 
of an efficacious allergen immunotherapy (AIT) for IBH has been ham-
pered by the lack of pure Culicoides allergens. The use of Culicoides 
whole-body extracts (WBEs) usually leads to low specificity and sen-
sitivity of serological tests25-29 and to low efficacy of AIT.30,31 While 
a recent study showed a better performance of IgE serology using a 
WBE from Culicoides obsoletus captured individually from horses in the 
field,32 this collection is very laborious and does not allow for stan-
dardization of the extract.33 C obsoletus cannot be bred under labora-
tory conditions.9 IBH-affected horses also react to Culicoides species 
not present in the environment of the horses indicating the presence 
of cross-reactivity between allergens of Culicoides species.34 Indeed, 
some allergens derived from different Culicoides species display high 
similarities (>70%) of the amino acid sequences,18 while others do 
not. Consequently, various studies aiming at the characterization of 
Culicoides salivary proteins have been performed8,35 and have resulted 
in the production of over 20 Culicoides r-allergens, derived from C. nu-
beculosus,5,17 C obsoletus16,18 and C sonorensis.27 The majority of the 
Culicoides r-allergens have been produced in E coli, and few in insect 
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G R A P H I C A L  A B S T R A C T
In this study, we identify and produce eight new Culicoides r-allergens, Cul o 8 to Cul o 15. Out of 27 tested Culicoides r-allergens, nine 
are major allergens for IBH and seven bind serum IgE in > 70% of the IBH-affected horses. Combination of these seven r-allergens could 
diagnose > 90% of IBH horses with a specificity > 95%.
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cells or barley.18,27,36 A first study using a microarray including a limited 
panel of ten C nubeculosus and two C obsoletus r-allergens suggested 
a highly discriminatory potential for this technique. It showed that 
horses with IBH have a high probability of being classified separately 
from those affected with other allergic disease and from healthy con-
trol horses, suggesting that this approach is worth being refined for 
studying the sensitization pattern to Culicoides r-allergens in IBH.37
Using a large, comprehensive panel of Culicoides r-allergens printed 
on a microarray, the aim of the study was to determine which of these 
Culicoides r-allergens are most important for IBH and should be lead 
compounds for AIT and be included in diagnostic tests for IBH. A fur-
ther aim was to compare IgE binding to r-allergens produced in differ-
ent expression systems.
2  | MATERIAL S AND METHODS
2.1 | Horses
Sera from 347 horses, 148 healthy controls and 199 IBH-affected horses 
were tested for allergen-specific IgE (Table 1). The serum samples came 
from five different countries and were collected during the IBH seasons 
in the years 2005 to 2017. All horses with IBH showed the typical, sea-
sonally recurrent clinical signs,5 while the healthy control horses (H), all 
living in the same environments as the IBH horses, had no clinical signs or 
history of skin diseases. Additionally, in the Swiss horses, clinical diagnosis 
of IBH had been confirmed in an in vitro sulfidoleukotriene release assay 
with Culicoides allergens.20,38 The horses belonged to different breeds 
with a predominance of the Icelandic breed (Table 1). All IBH-affected 
Icelandic horses had been imported from Iceland as well as 89 of the 115 
H Icelandic horses. The study was approved by the Animal Experimental 
Committee of the Canton of Berne, Switzerland (No. BE 121/05 and BE 
2/17), and by an ethics committee and the State Office for Consumer 
Protection and Food Safety in accordance with the German Animal 
Welfare Law (LAVES—Reference Number: 33.14 42502-04-14/1718).
2.2 | New recombinant Culicoides allergens
Eight previously unpublished proteins from C obsoletus were included 
on the array. Their sequences were derived from cDNA synthesized 
using wild C obsoletus salivary glands prepared as described.35 The 
cDNA was analysed by next-generation sequencing at the University 
of Bristol Genomics Facility, using ion proton sequencing. The data 
were assembled into full-length mRNA using the de novo assem-
bly software “Trinity” and the University of Bristol Supercomputing 
Facility, BlueCrystal. They were named and numbered according to the 
allergen nomenclature (allergen.org), Cul o 8 to Cul o 15 (Table 2). The 
sequences were codon-optimized for expression in E coli, synthesized 
and cloned into pET100/D-TOPO (GeneArt® Gene Synthesis, Thermo 
Fisher). Proteins were expressed in E coli BL21(DE3) grown either in 
100 mL of AIM (auto-induction medium super broth, www.forme dium.
com) for 18 hours,39 or overnight in Cinnabar medium (www.tekno 
va.com) with 100 µmol/L IPTG (isopropyl β-D-1-thiogalactopyranoside) 
added for a further 4 hours of culture before harvest. The culture was 
centrifuged at 8000 × g for 5 minutes at 4°C. To reduce LPS content, 
the pellet was washed with 100 mmol/L Tris (pH 8.0), followed by 
100 mmol/L Tris (pH 8.0), 5 mmol/L CaCl2 and then 100 mmol/L Tris 
(pH 8.0), and 10 mmol/L EDTA. The wash cycle was repeated with 
each buffer with two final washes in 100 mmol Tris to remove EDTA 
before freezing at −20°C.40 After thawing, the pellet was resuspended 
in NZY lysis buffer with lysozyme, DNase (www.nzyte ch.com) and 
protease inhibitor cocktail (cOmplete Tablets, Roche) and incubated 
at RT for 1 hour before centrifugation at 16.000 × g for 10 minutes 
at 4°C. The pelleted inclusion bodies were washed with Tris buffer 
containing Triton X-114 for LPS removal according to Choi et al40 
and then resuspended in 50 mmol/L Tris (pH 8.0), 500 mmol/L NaCl, 
20 mmol/L imidazole, 8 mol/L urea, 5 mmol/L TECP and rocket O/N at 
RT subsequently centrifuged at 16.000 × g and the supernatant har-
vested. The supernatant was applied to Ni-SepharoseTM 6 Fast Flow 
(GE Healthcare) for purification of His-tagged proteins according to 
manufacturer's procedures. After elution, the proteins were refolded 
in 400 mmol/L Arginine-HCL, 20 mmol/L Tris, pH 8, 500 mmol/L NaCl, 
5 mmol/L b-cyclodextrin 100 mmol/L glycerol, 340 mmol/L imidazole, 
0.2 mmol/L oxidized glutathione and 2 mmol/L reduced glutathione.
2.3 | Allergens used in the study
The allergens used included a total of 27 Culicoides r-allergen: 
eleven C nubeculosus (Cul n,17,41 eight already published C obsole-
tus r-proteins (Cul o16,18) and the eight new C obsoletus r-allergens 
(Table 2). The allergens had been expressed not only in E coli as 
described17,18,41 but also in barley, insect cells36 and yeast (Pichia 
Country
Icelandic horses Other breeds All breeds
H IBH H IBH H IBH Total
Switzerland (CH) 67 59 22 25 89 84 173
Germany (DE) 11 5 — 5 11 10 21
Sweden (SE)26 37 56 — — 37 56 93
Ireland (IRL) — — 11 21 11 21 32
United Kingdom 
(UK)
— — — 28 — 28 28
Total 115 120 33 79 148 199 347
TA B L E  1   Origin of the horses affected 
with insect bite hypersensitivity (IBH) and 
of the healthy control (H) horses used 
for the determination of allergen-specific 
serum IgE on the microarray. A total of 
347 horses were included, of which 235 
horses belonged to the Icelandic breed. 
The other 112 horses belonged to various 
breeds
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pastoris, VALIDOGEN GMBH (formerly VTU Technology), Grambach, 
AT),42 resulting in a total of 44 Culicoides r-proteins included on the 
array (Table 2 and Table S1).
Additionally, a Cul n thorax extract (CN-TE43) and a whole-body 
extract from Cul o group midges (CO-WBE)16 as well as a black fly 
extract (Simulium vittatum [SV-WBE]44 were used. As negative con-
trol antigens, the recombinant mould allergen Alternaria alternate 1 
(Alt a 1, Biomay, www.biomay.com) and a house dust mite extract 
(Dermatophagoides farinae [Der f], Stallergenes Greer, www.stall ergen 
esgre er.com) were also assessed (Table 2).
2.4 | Serum IgE testing by protein microarray
IgE serum determination by protein microarray was performed as 
described.45 All serum samples had been kept frozen until used and 
were tested in the same period, within few months.
Briefly, all proteins and extracts were normalized to 0.5 µg/mL 
protein before being printed onto Grace Bio-Labs Oncyte® Nova™ 
nitrocellulose film slides using a Marathon microarrayer (Arrayjet, 
Roslin, Scotland). The slides were blocked with 3% BSA in PBS for 
3h with rotation at 37°C. Slides were subsequently washed in 0.05% 
TA B L E  2   Culicoides nubeculosus (Cul n) and Culicoides obsoletus (Cul o) recombinant allergens produced in E coli (coli), baculovirus-
infected insect cells (Baculo), yeast (Pichia) or barley. In a part of the analyses, only one expression system was chosen per allergen (in bold). 
Additionally, Cul n thorax extract (CN-TE), Cul o group whole-body extract (CO-WBE) and Simulium vittatum whole-body extract (SV-WBE) 
were used. Alternaria alternate 1 (alt a 1) and Dermatophagoides farinae (Der f) were used as control antigens, not relevant for IBH
Name Expression system Protein family GenBank Reference
Cul n 1 Baculo PR1-like (antigen-5 like) EU978899 Schaffartzik et al (2010)
Cul n 2 Baculo, Coli Hyaluronidase HM145950 Schaffartzik et al (2011)
Cul n 3 Baculo, Coli, Barley DUF4803 superfamilya  HM145951.1 Schaffartzik et al (2011); Jonsdottir et al (2018)
Cul n 4 Baculo, Coli, Barley, Pichia Unknown HM145952 Schaffartzik et al (2011); Jonsdottir et al (2018)
Cul n 5 Coli DUF4803 superfamily HM145953 Schaffartzik et al (2011)
Cul n 6 Coli Unknown HM145954 Schaffartzik et al (2011)
Cul n 7 Coli Unknown HM145955 Schaffartzik et al (2011)
Cul n 8 Baculo, Coli, Pichia Maltase (alpha amylase) HM145956 Schaffartzik et al (2011)
Cul n 9 Coli D7-related/OBP HM145957 Schaffartzik et al (2011)
Cul n 10 Coli DUF4803 superfamily HM145958 Schaffartzik et al (2011)
Cul n 11 Coli Serine protease/trypsin HM145959 Schaffartzik et al (2011)
Cul o 1P Coli Kunitz protease inhibitor JX512273 Peeters et al (2013)
Cul o 2 Baculo, Pichia Hyaluronidase KC339672 Van der Meide et al (2013)
Cul o 2P Baculo, Coli D7-related/OBP JX512274 Peeters et al (2013)
Cul o 3 Baculo, Coli, Pichia PR1-like (antigen-5 like) KC339673 Van der Meide et al (2013)
Cul o 3P Coli D7-related/OBP JX512275 Not published
Cul o 5 Baculo, Coli Unknown KC339675 Van der Meide et al (2013)
Cul o 6 Coli, Pichia D7-related/ OBP KC339676 Van der Meide et al (2013)
Cul o 7 Baculo, Coli, Pichia Unknown KC339677 Van der Meide et al (2013)
Cul o 8 Coli Kunitz protease inhibitor MN123710 New, clone CO145
Cul o 9 Coli WSC superfamily, carbohydrate-
binding domain
MN123712 New, clone CO120
Cul o 10 Coli DUF4803 superfamily MN123711 New, clone CO180
Cul o 11 Coli Apolipophorin III-like MN123713 New, clone CO167
Cul o 12 Coli Leucine-rich repeat MN123714 New, clone CO15
Cul o 13 Coli D7-related/OBP MN123715 New, clone CO13
Cul o 14 Coli Serine protease/trypsin MN123716 New, clone CO60
Cul o 15 Coli, Baculo Apyrase MN123717 New, clone CO147
CN-TE Extract Ziegler et al (2018)
SV-WBE Extract Torsteinsdottir et al (2018)
CO-WBE Extract
Alt a 1 Coli Biomay
Der f Extract Stallergenes Greer
aDomain of unknown function. 
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PBS-T followed by washes with Milli-Q water (Millipore) before being 
dried via centrifugation at 300 × g for 10 minutes. Slides were fitted 
with ProPlate slide modules (Grace Bio-Labs), and the 16 nitrocel-
lulose wells on the slide were washed three times with 150 μL/well 
0.2% PBS-T. The sera diluted 1:2 in 4% BSA-0.4% PBS-T were applied 
to each well (100 μL/well), except for one used as blank (0.2% PBS-T). 
These slides were incubated O/N at 4°C at 13 oscillations/min (Stuart 
SSL4 See-saw Rocker). After washing with 0.05% PBS-T, anti-horse 
IgE mAb 3H1046 diluted 1:400 in 0.2% PBS-T and 1% BSA was added 
(100 μL/well) and incubated at 37°C for 2 hours. After washing with 
0.05% PBS-T, DyLight 649-conjugated anti-mouse IgG1 (Rockland, 
#610-443-040) was applied at dilution 1:400 in 0.2% PBS-T and 1% 
BSA. After final washes, the slides were dried by centrifugation. The 
pads were scanned in a GenePix4000B (Molecular Devices, Inc). The 
mean of the blanks with each allergen was subtracted from the values 
obtained with the serum samples before further analyses of the data. 
Data were presented as fluorescence arbitrary unit (FAU).
2.5 | Data analysis
For statistical analysis, NCSS software (NCSS 12 Statistical Software 
(2018), NCSS, LLC; ncss.com/software/ncss) was used. Since the 
data were not normally distributed, descriptive statistics using me-
dian and ranges and the Mann-Whitney U test to compare IgE val-
ues between IBH-affected and H control horses were performed.
In a second step, the capacity of the single allergens to discrim-
inate IBH-affected from H horses was investigated by receiver op-
erator characteristic (ROC) curves, with the accuracy of the test 
represented by the area under the curve (AUC).
Spearman rank correlation was used to compare IgE levels of r-al-
lergens expressed in different expression systems.
When the same r-allergens were produced in different expression 
systems, one of them was chosen for further analyses: r-allergens with 
the best AUC were selected, and when the AUCs were similar, dot 
plot graphs helped to select the allergen giving the best separation 
between the IBH-affected and control group (not shown).
ROC curves were used to select the optimal cut-off values. As 
cut-off, values giving at least a specificity of 94% at the highest ac-
curacy possible were selected. For each allergen, specific IgE values 
were then transformed in positive and negative (above and below cut-
off level) results. The 2-sided Fisher's exact test was used to compare 
the proportion of IBH-affected and control horses with positive al-
lergen-specific IgE results or to compare the proportion of positive 
results between Icelandic (ISL) and other breeds within IBH-affected 
or H horses.
F I G U R E  1   Comparison of IgE values 
in fluorescence arbitrary units (FAU) 
to recombinant allergens expressed in 
different expression systems, exemplified 
for Cul n 3 (A) and Cul n 4 (B). Every peak 
shows the IgE values of one horse on the 
allergen expressed in insect cells (Baculo; 
red square), in barley (green triangle), E coli 
(Coli; blue rhomboid) and Pichia pastoris 
(Pichia; violet cross; only Cul n 4). IgE 
values of the 148 healthy control horses 
are represented on the left side and of 
the 199 IBH-affected horses on the right 
side of the abscissa
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To determine which combination of r-allergens would result in 
the best sensitivity and specificity, multivariable logistic regression 
analyses were performed with IBH status as the outcome and se-
ropositivity to the different allergens as potential predictors. The 
model was built in a stepwise forward selection process, with the 
r-allergen with the best AUC entering the model first, followed by 
the allergen with the next best value. Inclusion of allergens was 
stopped after adding new allergens did not result in an improvement 
of sensitivity and specificity.
3  | RESULTS
3.1 | Comparison and selection of allergens 
produced in different expression systems
A total of 27 different Culicoides r-allergens, some of which were ex-
pressed in different expression systems, resulting in a total of 44 
r-allergens, were analysed in this study. Median serum IgE values of 
IBH-affected and control horses and AUCs for each of these aller-
gens are shown in Table S1. The horses usually displayed similar IgE 
reactivity patterns to the same r-allergen produced in the different 
expression systems (shown for Cul n 3 and Cul n 4 in Figure 1A,B), 
although insect cell–expressed Cul n 3 bound serum IgE from H 
horses more frequently than Cul n 3 expressed in the other systems. 
IgE levels to the same allergen expressed in various systems usually 
correlated rather well (R: 0.63-0.91, P < .001), with few exceptions, 
as shown in Table 3.
3.2 | Allergen-specific IgE levels in IBH-affected and 
control horses
Comparison of allergen-specific IgE levels between IBH-affected 
and H control horses was first performed country-wise by ROC 
curves and Mann-Whitney U test. The AUCs were statistically sig-
nificant for all 27 recombinant Culicoides allergens in the horses 
from Switzerland (CH) and almost all r-allergens in the horses from 
Sweden (SE: 25/27 r-allergens), Ireland (IRL: 24/ 27 r-allergens) and 
Germany (DE: 26/ 27 r-allergens) (Table S2). Interestingly, the horses 
from Germany displayed higher AUC for most Culicoides r-allergens 
and in particular for the Cul n allergens compared with the horses 
from the other countries (Table S2).
The IgE-binding capacity of the allergens printed on the microarray 
varied greatly between allergens (Table 4), with allergens showing low 
values such as Cul n 2 or Cul n 5, while some other allergens gave a 
very strong signal with sera from IBH-affected horses, such as Cul o 1P 
and Cul o 8. For some of these allergens, IgE binding in the control sera 
was also higher. Irrespective of these differences between allergens, 
significant differences for median IgE levels between IBH-affected and 
control horses were found for all tested Culicoides allergens, except 
Cul n 7. Further analysis using ROC curves revealed that in our study 
population, some allergens had a very good performance to discrim-
inate IBH-affected from H control horses with AUC > 0.90. This was 
the case for the six Cul o allergens, Cul o 1P, Cul o 2P, Cul o 8, Cul o 
9, Cul o 11 and Cul o 10. AUC values between 0.80 and 0.90 were 
obtained for five Culicoides r-allergens (Cul o 3, Cul o 5, Cul o 7, Cul o 
12, Cul o 13) as well as for the two Culicoides extracts.
3.3 | Analysis of the data after cut-off definition
For further analysis, the IgE results were grouped in positive or 
negative test results based on the cut-off value chosen at a speci-
ficity ≥ 94% (Table 4). Cut-offs selected based on Youden's index, 
that is, when the sum of the sensitivity and specificity is maximized, 
are shown in Table S3. For the three Cul o r-allergens, Cul o 1P, Cul 
o 8 and Cul o 10, the same cut-off values as when using a speci-
ficity > 94% were selected based on Youden's index. For the other 
r-allergens, the cut-off values were usually lower, resulting in an in-
creased sensitivity with some loss of specificity. Comparison of the 
number of positive IgE reactions between IBH-affected and H con-
trol horses in Fisher's exact test revealed significant differences for 
all Culicoides r-allergens, except for Cul n 7 and Cul n 8. Figure 2 
shows that the allergens Cul o 8, Cul o 1P and Cul o 2P bound serum 
IgE in > 80% of the IBH-affected horses followed by Cul o 10, Cul o 
9, Cul o 11 and Cul o 7 with > 70% positive reactions. The allergens 
Cul o 5 and Cul o 3 bound IgE in > 50% of the allergic horse sera. The 
remaining r-allergens gave less frequently positive reactions in the 
TA B L E  3   Spearman's correlations per allergen between the 
proteins expressed using different expression systems: E coli (coli), 
baculovirus-infected insect cells (Baculo), barley and yeast (Pichia). 
All correlations were significant (P < .001)
Allergen
Correlation 
Matrix Baculo Barley Pichia
Cul n 2 Coli 0.50 n.a.a  n.a.
Cul n 3 Coli 0.63 0.73 n.a.
Baculo 1.00 0.80 n.a.
Cul n 4 Coli 0.75 0.74 0.71
Baculo 1.00 0.91 0.86
Barley 0.91 1.00 0.89
Cul n 8 Coli 0.52 n.a 0.89
Baculo 1.00 n.a. 0.48
Cul o 2 Baculo 1.00 n.a. 0.28
Cul o 2P Coli 0.78 n.a. n.a.
Cul o 3 Coli 0.70 n.a. 0.66
Baculo 1.00 n.a. 0.76
Cul o 5 Coli 0.75 n.a. n.a.
Cul o 6 Coli n.a. n.a. 0.38
Cul o 7 Coli 0.88 n.a. 0.76
Baculo 1.00 n.a. 0.74
Cul o 15 Coli 0.32 n.a. n.a.
aNot applicable. 
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IBH-affected group, with values ranging between 42% (Cul o 13) and 
14% (Cul o 15). With the cut-offs selected to achieve a high speci-
ficity (>94%), the percentage of IBH-affected horses with positive 
IgE levels to the Culicoides extracts was below 50% (CO-WBE 48%, 
CN-TH 42%) and was negligible with SV-WBE (12%). In Figure S1, the 
data of IBH-affected horses are shown for each country. While there 
are differences in the percentages of positive IgE reactions to the 
different allergens between the countries, this figure also confirms 
that the seven top allergens from Figure 2 are major allergens for 
IBH in all countries (except for Cul o 7 in England and Ireland).
3.4 | IgE reactions to the r-Culicoides allergens in 
Icelandic horses compared with other breeds
Comparison of the IgE results in the sera from the IBH-affected 
horses belonging to the ISL breed to other breeds shows that ISL 
horses have significantly more often positive reactions than the 
horses from other breeds. This was performed for the horses living in 
Switzerland only, as there was often an overlap between breed and 
country (Table 1). The difference was significant for 14 r-allergens 









Cul n 1 44 859 <.001 0.74 0.69 0.79 2500 0.30
Cul n 2 0 106 <.001 0.71 0.66 0.76 230 0.37
Cul n 3 605 4038 <.001 0.79 0.74 0.84 7500 0.38
Cul n 4 0 588 <.001 0.79 0.74 0.83 820 0.42
Cul n 5 1 82 <.001 0.77 0.72 0.81 108 0.43
Cul n 6 0 280 <.001 0.70 0.64 0.74 800 0.28
Cul n 7 131 201 n.s.a  0.54 0.48 0.60 2200 0.07
Cul n 8 678 1089 <.001 0.62 0.56 0.68 3950 0.12
Cul n 9 393 1141 <.001 0.74 0.68 0.78 2400 0.31
Cul n 10 307 858 <.001 0.67 0.61 0.72 3500 0.20
Cul n 11 0 239 <.001 0.64 0.58 0.69 1500 0.26
Cul o 1P 603 43 478 <.001 0.94 0.90 0.96 7300 0.83
Cul o 2 7 77 <.001 0.73 0.67 0.77 150 0.34
Cul o 2P 5 1549 <.001 0.94 0.91 0.96 300 0.82
Cul o 3 193 1259 <.001 0.88 0.83 0.91 1070 0.54
Cul o 3P 0 522 <.001 0.75 0.70 0.80 870 0.37
Cul o 5 1249 7766 <.001 0.85 0.80 0.88 6000 0.60
Cul o 6 17 164 <.001 0.79 0.74 0.83 238 0.41
Cul o 7 149 2854 <.001 0.88 0.84 0.91 900 0.71
Cul o 8 947 44 986 <.001 0.95 0.92 0.97 16 000 0.89
Cul o 9 37 19 070 <.001 0.92 0.89 0.95 1800 0.76
Cul o 10 0 6502 <.001 0.91 0.88 0.94 700 0.77
Cul o 11 3658 32 043 <.001 0.91 0.88 0.94 11 000 0.74
Cul o 12 0 480 <.001 0.85 0.80 0.88 488 0.49
Cul o 13 804 3981 <.001 0.84 0.79 0.88 5600 0.42
Cul o 14 0 68 <.001 0.71 0.65 0.76 160 0.36
Cul o 15 53 171 <.001 0.81 0.77 0.85 1100 0.14
CN-TE 216 940 <.001 0.81 0.76 0.85 1150 0.42
CO-WBE 261 1503 <.001 0.84 0.79 0.87 1550 0.48
SV-WBE 254 598 <.001 0.71 0.65 0.76 1800 0.12
Alt a 1 20 18 n.s 0.50 0.44 0.55 300 0.07
Der f 518 519 n.s. 0.52 0.45 0.58 3700 0.09
Note: Bold indicates the seven top Culicoides r-alleysis.
aNot significant (P > .05). 
TA B L E  4   Overview of allergen-specific 
IgE determined with a protein microarray 
in sera from 199 horses affected with 
insect bite hypersensitivity (IBH) and 148 
healthy control (H) horses. Median serum 
IgE values (in fluorescence arbitrary unit) 
from H and IBH-affected horses and P 
values from the Mann-Whitney U test. 
Results from ROC analyses are as well-
listed: pairwise accuracy (AUC) with lower 
and upper confidence limits, cut-off values 
selected to obtain a specificity ≥ 95% (CO-
WBE 94%) and the resulting sensitivities 
(sens.)
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and other breeds for the top five allergens Cul o 8, Cul o 1P, Cul o 2P, 
Cul o 10 and Cul o 9 (Figure 3). Interestingly, IBH-affected ISL horses 
living in Switzerland or in Sweden, that is in different environments, 
showed very similar sensitization patterns (Figure S2). There were no 
significant differences between the breeds in the H control horses.
3.5 | Selection of the best combination of allergens 
for diagnosis of IBH
In the multivariate logistic regression model, combination of the 
three best performing r-allergens, Cul o 8, Cul o 1P and Cul o 2P, 
resulted in a sensitivity of 90% with a specificity of 94%. Addition 
of the next four top allergens Cul o 10, Cul o 9, Cul o 11 and Cul o 7 
further increased the performance of the assay, resulting in a sensi-
tivity of 90% and specificity of 96% (AUC = 0.957, 95% confidence 
interval: 0.899 to 0.982). Country-wise analysis was performed for 
CH, SE, IRL and DE and showed that using this combination of seven 
allergens also resulted in high sensitivities (92% to 100%) and spe-
cificities (97% to 100%) within these countries.
4  | DISCUSSION
Our aim was to test a most complete panel of all Culicoides r-allergens 
available using a newly developed microarray for IgE serology.37,47 A 
total of 27 different Cul r-allergens of which eight were new aller-
gens were thus analysed in this study. A first country-wise analysis 
of the results using AUCs indicated that nearly all tested r-allergens 
were relevant for IBH, independently of the country of origin of the 
horses, while AUCs for the control allergens were nonsignificant. 
Horses from Germany reacted more often with Cul n r-allergens 
than horses living in other countries. This might be due to a higher 
presence of C nubeculosus in this geographical area. However, as this 
group only consisted of 10 IBH-affected horses, larger numbers of 
horses will need to be tested in the future to define the sensitization 
pattern in horses from Germany. Ideally, Culicoides species should 
also be determined in the environments where the horses have been 
sampled. Horses from all countries were then pooled for an overall 
analysis. After ROC analysis and cut-off determination, seven r-aller-
gens of Culicoides obsoletus group midges (Cul o 8, Cul o 1P, Cul o 2P, 
Cul o 10, Cul o 9, Cul o 11 and Cul o 7) were identified as the most 
relevant allergens for IBH, as between 74% and 89% of the IBH-
affected horses had positive IgE values against these r-allergens. The 
specificity was high, as only 5% of the H horses had IgE above the 
cut-off values. Supporting earlier findings by van der Meide et al,18 
the best performing r-allergens were all derived from Culicoides ob-
soletus and not Culicoides nubeculosus, showing the importance to 
test horses against the native and most frequent Culicoides spp. 
from their environment. Culicoides obsoletus group midges are the 
most commonly found species in Switzerland,48 Ireland,49 England,8 
Germany50 and Sweden.51 Consideration of the results from each 
country separately shows that the Culicoides r-allergens Cul o 8, Cul 
o 1P, Cul o 2P, Cul o 10, Cul o 9 and Cul o 11 are major allergens for 
all tested horses independently of their origin or breed. Cul o 1P and 
Cul o 2P already showed good results for differentiation between 
IBH-affected and H horses in Belgian Warmblood horses,16 but in 
that study no further r-Cul o allergens had been tested. Interestingly, 
the Irish group seems to be more often sensitized to Cul o3P, Cul o2P 
and Cul n 9 all belong to the D7 protein family, than the other horse 
groups. Comparison of the IgE results in IBH-affected horses from 
the ISL breed to those from other breeds shows that both groups 
are sensitized to a similar extend to the top r-allergens Cul o 8, Cul 
o 1P, Cul o 2P, Cul o 9 and Cul o 10. However, horses of the ISL 
breed have signficantly more often positive IgE results to other r-
allergens than non-Icelandic horses. This suggests that imported 
Icelandic horses developing IBH in Europe are sensitized to more 
Culicoides r-allergens than horses born on the European continent. 
In particular, Cul o 7, Cul o 5 and Cul o 3 seem to be very important 
allergens in ISL horses. Although we tested a rather large number 
of horse sera, a limitation of our study is that breed and country are 
F I G U R E  2   IgE levels to 27 recombinant Culicoides allergens. 
Percentage of horses with IgE levels above the cut-off values (as 
indicated in Table 4) in 199 IBH-affected and 148 healthy horses. 
The allergens are listed in decreasing order from those binding 
serum IgE in the highest number of IBH-affected horses. P values 
were calculated with Fisher's exact tests. The differences between 
healthy and IBH-affected horses were all significant (P < .05) 
except for Cul n 7 and Cul n 8
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often confounding factors, and the small groups from Ireland, United 
Kingdom and Germany may not be representative when analysed 
separately. Further studies with much larger numbers of samples are 
required to be able to investigate the effects of environment and 
breed on the sensitization pattern to Culicoides r-allergens.
Our study confirmed that a combination of r-allergens differen-
tiates better between IBH-affected and nonaffected horses than 
the use of single r-allergens or WBE.16,52,53 Only 45% and 42% of 
the IBH-affected horses were positive on CO-WBE and CN-TH, 
respectively, when a cut-off giving a high specificity was used. 
Combination of the top seven r-allergens in a logistic regression 
analysis could detect more than 90% of IBH-affected horses both 
overall and within each country, with a high specificity of > 95%. 
Combination of these 7 Culicoides r-allergens may thus be a pow-
erful tool for diagnostic purposes and should replace the use of 
crude WBE. However, as a rather large part of the horses are sen-
sitized to additional Culicoides salivary allergens, combination of 
these major allergens might not be sufficient for an effective AIT. 
This microarray will enable a component-resolved diagnosis as the 
basis for a patient-tailored AIT.
Most of our original panel of 44 r-allergens were expressed in 
E coli, followed by insect cells, yeast and barley. IgE binding to the 
same r-allergens expressed in different systems usually correlated 
well. Proteins can usually be expressed cheaply and in large quan-
tities in E coli, but are often insoluble in inclusion bodies and have 
to be refolded, and lack critical posttranslational modification. 
Other systems such as yeast glycosylate or even overglycosylate 
proteins can also lead to false-positive results.54 No clear trend 
towards one expression system could be seen when selecting 
the best performing r-allergen: From the 11 r-allergens that had 
been expressed in more than one expression system, five insect 
cell–expressed, four E coli–expressed and one each of yeast- and 
barley-expressed r-allergen were chosen. Van der Meide et al18 
compared the immunoreactivity between Cul o 1 expressed in E 
coli and insect cells and could not show an improved performance 
of the insect cell–expressed protein in IgE serology. Another study 
compared insect cell-, barley- and E coli–expressed allergens and 
showed that they performed quite similarly in serology, while E coli 
produced allergens were not suited for cellular assays.36 However, 
as purified natural Culicoides allergens are not available, we can-
not assess the IgE-binding capability of the r-Culicoides salivary 
proteins in comparison with the natural allergens. A limitation of 
our study is thus that some of the Culicoides r-proteins may be 
misfolded, resulting in a decrease in their IgE-binding capacity and 
thus to an under-estimation of the number of major Culicoides al-
lergens for IBH. Methods to determine the biological activity of 
Culicoides salivary proteins need to be established in order to in-
vestigate whether and in which expression system correctly re-
folded Culicoides r-allergens can be produced.
In conclusion, this study shows that seven Culicoides obsoletus 
r-allergens, of which four are newly expressed allergens, are very 
important allergens for IBH as they bind serum IgE in > 70% of 
IBH-affected horses of various breeds and origins within central 
and northern Europe. Combination of these r-allergens results in a 
highly specific and sensitive serological test for in vitro diagnosis of 
IBH. In addition, this microarray with Culicoides r-allergens could be 
a powerful tool for the development of component-resolved, pa-
tient-tailored allergen-specific immunotherapy for IBH. Finally, this 
technique could also be useful to investigate sensitization profiles in 
human patients allergic to biting midges.
F I G U R E  3   Comparison of the IgE 
levels (shown as % horses with IgE 
levels above cut off values) to the 27 
recombinant Culicoides allergens between 
IBH-affected horses from the Icelandic 
breed (n = 120) versus horses belonging 
to other breeds (n = 79) within the horse 
group from Switzerland. Significant 
differences between groups in Fisher's 
exact test are shown with a star
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